European authorities suspend Mylan's manufacturing license for hypertension drug

Mylan NV ’s manufacturing license for valsartan was suspended by European authorities after NDEA was found in some batches of the hypertension drug made at the company’s facility in Hyderabad, India, The European Medicals Agency said on Monday. Suspension of Mylan’s (Nasdaq: MYL) certificate of compl iance with European standards for quality testing effectively prohibits the use of its valsartan in EU medicines, EMA’s release said. NDEA in high doses is classified as a substance that could…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news